Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-29T09:17:36.677Z Has data issue: false hasContentIssue false
  • English
  • Français

Cognitive performance following fluoxetine treatment in depressed patients post myocardial infarction

Published online by Cambridge University Press:  24 June 2014

Jacqueline J. M. H. Strik ,
Adriaan Honig ,
Edwin Klinkenberg ,
Jeanette Dijkstra  and
Jelle Jolles
Jacqueline J. M. H. Strik*
Affiliation:
Department of Psychiatry, University Hospital Maastricht/University of Maastricht, The Netherlands
Adriaan Honig
Affiliation:
Department of Psychiatry, University Hospital Maastricht/University of Maastricht, The Netherlands
Edwin Klinkenberg
Affiliation:
Department of Psychiatry, University Hospital Maastricht/University of Maastricht, The Netherlands
Jeanette Dijkstra
Affiliation:
Department of Psychiatry, University Hospital Maastricht/University of Maastricht, The Netherlands
Jelle Jolles
Affiliation:
Department of Psychiatry, University Hospital Maastricht/University of Maastricht, The Netherlands
*
Jacqueline Strik, MD, PhD, RIAGG Maastricht, Parallelweg 45/47, 6221 BD Maastricht, The Netherlands. Tel: +31 43 3299699; Fax: +31 43 3299656; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background:

As depression is a considerable risk factor for an unfavourable course of myocardial infarction (MI), antidepressant treatment of post-MI depression and, inherent to MI status, polypharmacy has become an important issue.

Objective:

The present study is the first to evaluate cognitive side effects of fluoxetine, as part of a placebo-controlled double-blind trial, in patients with post-first MI depression.

Methods:

Cognitive performance of 54 depressed patients post first-MI, treated with fluoxetine or placebo was compared. Cognitive performance was tested before and after 9 weeks of treatment using the Visual Verbal Learning Test, Concept Shifting Task, Stroop Colour-Word Test and Letter-Digit-Substitution Test.

Results:

The median number of cardiovascular drugs taken by MI patients was 4.9. There were no differences between the fluoxetine and the placebo group on cognitive performance.

Conclusion:

In sum, there were no negative side effects of fluoxetine compared with placebo on cognition in depressed MI patients, simultaneously treated with cardiac drugs.

Keywords

cognitiondepressionfluoxetinemyocardial infarctionside effects
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 18 , Issue 1 , February 2006 , pp. 1 - 6
Copyright
Copyright © 2006 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Frasure-Smith, N, Lesperance, F, Talajic, M. Depression following myocardial infarction: impact on 6-months survival. JAMA 1993;270: 999–1005. CrossRefGoogle Scholar
Forrester, AW, Lipsey, JR, Teitelbaum, MLet al. Depression following myocardial infarction. Int J Psychiatry Med 1992;22: 33–46. CrossRefGoogle ScholarPubMed
Honig, A, Lousberg, R, Wojchiechowski, Fet al. Depression following a first heart infarct; similarities with and difference from ‘ordinary’ depression. Ned Tijdschr Geneeskd 1997;141: 196–199. Google ScholarPubMed
Roose, SP, Dalack, GW, Woodring, S. Death, depression and heart disease. J Clin Psychiatry 1991;52 (6 Suppl.):34–39. Google ScholarPubMed
Strik, JJMH, Denollet, J, Lousberg, Ret al. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003;42: 1801–1807. CrossRefGoogle ScholarPubMed
Carney, RM, Freedland, KE, Veith, RCet al. Can treating depression reduce mortality after an acute myocardial infarction? Psychosom Med 1999;61: 666–675. CrossRefGoogle ScholarPubMed
Lane, D, Carroll, D, Ring, Cet al. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001;63: 221–230. CrossRefGoogle ScholarPubMed
Mayou, RA, Gill, D, Thompson, DRet al. Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 2000;62: 212–219. CrossRefGoogle ScholarPubMed
Mayou, R, Foster, A, Williamson, B. Psychosocial adjustment in patients one year after myocardial infarction. J Psychosom Res 1978;22: 447–453. CrossRefGoogle ScholarPubMed
Blumenthal, JA, Williams, RS, Wallace, AGet al. Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom Med 1982;44: 519–527. CrossRefGoogle ScholarPubMed
Lane, D, Carroll, D, Ring, Cet al. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res 2001;51: 497–501. CrossRefGoogle ScholarPubMed
Menting, JEA, Honig, A, Verhey, FRJet al. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects. Int Clin Psychopharm 1996;11: 165–175. CrossRefGoogle ScholarPubMed
Strik, JJMH, Honig, A, Lousberg, Ret al. Efficacy and safety of fluoxetine in the treatment of patients with major depression following first myocardial infarction: findings from a double-blind placebo-controlled trial. Psychosom Med 2000;62: 783–789. CrossRefGoogle Scholar
Amado-Boccara, I, Gougoulis, N, Poirier Littre, MFet al. Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 1995;19: 479–493. CrossRefGoogle ScholarPubMed
Hindmarch, I. A pharmacological profile of fluoxetine and other antidepressants on aspects of skilled performance and car handling ability. Br J Psychiatry Suppl 1988; 35: 99–104. CrossRefGoogle Scholar
Hindmarch, I, Kerr, J. Behavioural toxicity of antidepressants with particular reference to moclobemide. Psychopharmacology 1992;106 (Suppl.):S49–S55. CrossRefGoogle ScholarPubMed
Hindmarch, I, Bhatti, JZ. Psychopharmacological effects of sertraline in normal, healthy volunteers. Eur J Clin Pharmacol 1988;35: 221–223. CrossRefGoogle ScholarPubMed
Podewils, LJ, Lyketsos, CG. Tricyclic antidepressants and cognitive decline. Psychosomatics 2002;43: 31–35. CrossRefGoogle ScholarPubMed
Lamping, DL, Spring, B, Gelenberg, AJ. Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study. Psychopharmacology 1984;84: 254–261. CrossRefGoogle ScholarPubMed
Fairweather, DB, Kerr, JS, Harisson, DAet al. A double-blind comparison of the effects of fluoxitine and amitripyline on cognitive function in elderly depressed patients. Hum Psychopharmacol 1993;8: 41–47. CrossRefGoogle Scholar
Cassano, GB, Puca, F, Scapicchio, PLet al. Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. J Clin Psychiatry 2002;63: 396–402. CrossRefGoogle ScholarPubMed
Krabbendam, L, Derix, MM, Honig, Aet al. Cognitive performance in relation to MRI temporal lobe volume in schizophrenic patients and healthy control subjects. J Neuropsychiatry Clin Neurosci 2000;12: 251–256. CrossRefGoogle ScholarPubMed
Visser, PJ, Verhey, FR, Ponds, RWet al. Distinction between preclinical Alzheimer's disease and depression. J Am Geriatr Soc 2000;48: 479–484. CrossRefGoogle ScholarPubMed
Moller, JT, Cluitmans, P, Rasmussen, LSet al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction[see comments][published erratum appears in Lancet 1998;351 (9117): 1742]. Lancet 1998;351: 857–861. CrossRefGoogle Scholar
Pasternak, RC, Braunwald, E, Sobel, RE. Acute myocardial infarction. In: Braunwald, E, ed. Heart disease: a textbook of cardiovascular medicine. 4th edn, Philadelphia: W.B. Saunders Compagny, 1992: 1200–1291. Google Scholar
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23: 56–62. CrossRefGoogle ScholarPubMed
Brand, N, Jolles, J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 1985;112: 201–210. CrossRefGoogle ScholarPubMed
Riedel, WJ, Klaassen, T, Honig, Aet al. 5-HT challenge and cognition in major depression and healthy control subjects. J Psychopharmacol 1998;12 (3A):16. Google Scholar
Lezak, MD. Neuropsychologiocal assessment. 3rd edn, New York: Oxford University Press, 1995. Google Scholar
Taylor, CB, Miller, NH, Smith, PM. Prevention of depression and anxiety in patients with cardiovascular disease. J Prev Interv Commun 1996;13: 53–69. CrossRefGoogle Scholar
Jolles, J, Houx, PJ, Van Boxtel, MPJet al. The Maastricht aging study: determinants of cognitive aging. Maastricht, The Netherlands: Neuropsych Publishers, 1995. Google Scholar
Reitan, RM. Validity of the Trail Making Test as an indication of organic brain damage. Percept Mot Skills 1958;8: 271–276. CrossRefGoogle Scholar
Dijkstra, JB, Houx, PJ, Jolles, J. Cognition after major surgery in the elderly: test performance and complaints. Br J Anaesth 1999;82: 867–874. CrossRefGoogle ScholarPubMed
Norusis, MJ. SPSS for Windows 6.0. Chicago: SPSS Inc. 1993. Google Scholar
Knapp, RG, Miller, MC. Clinical epidemiology and biostatistics. Baltimore: Williams & Wilkins, 1992. Google Scholar
De Bie, SE. Standard questions 1987: proposal for uniformisation of questions regarding background variables and interviews. 2nd edn. Leiden, The Netherlands: Leiden University Press, 1987. Google Scholar
Geretsegger, C, Bohmer, F, Ludwig, M. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects. Int Clin Psychopharmacol 1994;9: 25–29. CrossRefGoogle ScholarPubMed
Nebes, RD, Pollock, BG, Mulsant, BHet al. Cognitive effects of paroxetine in older depressed patients. J Clin Psychiatry 1999;60: 26–29. Google ScholarPubMed
Dijkstra, JB, Strik, JJMH, Honig, Aet al. Atypical cognitive profile in patients with depression after myocardial infarction. J Affect Disord 2002;70: 181–190. CrossRefGoogle ScholarPubMed
Young, RC, Mattis, S, Alexopoulos, GSet al. Verbal memory and plasma drug concentrations in elderly depressives treated with nortriptyline. Psychopharmacol Bull 1991;27: 291–294. Google ScholarPubMed
Teri, L, Reifler, BV, Veith, RCet al. Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition. J Gerontol 1991;46: P372–P377. CrossRefGoogle ScholarPubMed